- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 17/08 - Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
Patent holdings for IPC class C07K 17/08
Total number of patents in this class: 388
10-year publication summary
28
|
24
|
28
|
25
|
23
|
23
|
19
|
15
|
19
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Johns Hopkins University | 5662 |
11 |
Nektar Therapeutics | 436 |
9 |
Board of Regents, The University of Texas System | 5782 |
7 |
Biosteed Gene Expression Tech. Co., Ltd. | 10 |
6 |
Sekisui Chemical Co., Ltd. | 3386 |
6 |
Merck Millipore Ltd. | 35 |
6 |
Centre National de La Recherche Scientifique | 10418 |
5 |
JSR Corporation | 2512 |
5 |
Molecular Partners AG | 107 |
5 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1348 |
5 |
Benhealth Biopharmaceutic (Shenzhen) Co., Ltd. | 10 |
5 |
The Regents of the University of California | 19887 |
4 |
President and Fellows of Harvard College | 5972 |
4 |
Aebi Ltd. | 6 |
4 |
Jiangsu Hengrui Medicine Co., Ltd. | 706 |
4 |
Ohio State Innovation Foundation | 2123 |
4 |
Horizon Therapeutics USA, Inc. | 56 |
4 |
Bayer HealthCare LLC | 1361 |
3 |
Ambrx, Inc. | 181 |
3 |
Hadasit Medical Research Services & Development Limited | 138 |
3 |
Other owners | 285 |